Eliglustat
|
E413855-25mg
|
Moligand™, ≥98% |
491833-29-5 |
25mg
|
¥ 1852.9
|
现货 |
阿拉丁 |
Eliglustat
|
E413855-10mg
|
Moligand™, ≥98% |
491833-29-5 |
10mg
|
¥ 889.9
|
现货 |
阿拉丁 |
Eliglustat
|
E413855-100mg
|
Moligand™, ≥98% |
491833-29-5 |
100mg
|
¥ 5042.9
|
现货 |
阿拉丁 |
硫代硫胺素
|
O335915-5mg
|
≥97% |
490-82-4 |
5mg
|
¥ 629.9
|
现货 |
阿拉丁 |
硫代硫胺素
|
O335915-50mg
|
≥97% |
490-82-4 |
50mg
|
¥ 2999.9
|
现货 |
阿拉丁 |
硫代硫胺素
|
O335915-10mg
|
≥97% |
490-82-4 |
10mg
|
¥ 898.9
|
现货 |
阿拉丁 |
AKR1C1-IN-1
|
A412533-50mg
|
≥98% |
4906-68-7 |
50mg
|
¥ 535.9
|
现货 |
阿拉丁 |
AKR1C1-IN-1
|
A412533-100mg
|
≥98% |
4906-68-7 |
100mg
|
¥ 958.9
|
现货 |
阿拉丁 |
(S) -(+)-(3,5-二氧杂-4-膦-环庚[2,1-a;3,4-a']二萘-4-基)苄基(甲基)胺
|
D359411-250mg
|
≥99% |
490023-37-5 |
250mg
|
¥ 325.9
|
现货 |
阿拉丁 |
(S) -(+)-(3,5-二氧杂-4-膦-环庚[2,1-a;3,4-a']二萘-4-基)苄基(甲基)胺
|
D359411-1g
|
≥99% |
490023-37-5 |
1g
|
¥ 989.9
|
现货 |
阿拉丁 |
克酮酸
|
C153830-100mg
|
≥95%(HPLC) |
488-86-8 |
100mg
|
¥ 157.9
|
现货 |
阿拉丁 |
2-甲基-4-羰基-2-环己烯-1-羧酸乙酯
|
E135921-500g
|
≥97% |
487-51-4 |
500g
|
¥ 4673.9
|
现货 |
阿拉丁 |
2-甲基-4-羰基-2-环己烯-1-羧酸乙酯
|
E135921-25g
|
≥97% |
487-51-4 |
25g
|
¥ 232.9
|
现货 |
阿拉丁 |
Phillygenin
|
P414357-5mg
|
≥98% |
487-39-8 |
5mg
|
¥ 495.9
|
现货 |
阿拉丁 |
Phillygenin
|
P414357-50mg
|
≥98% |
487-39-8 |
50mg
|
¥ 3089.9
|
现货 |
阿拉丁 |
Phillygenin
|
P414357-25mg
|
≥98% |
487-39-8 |
25mg
|
¥ 1760.9
|
现货 |
阿拉丁 |
Phillygenin
|
P414357-100mg
|
≥98% |
487-39-8 |
100mg
|
¥ 4097.9
|
现货 |
阿拉丁 |
N-甲基金雀花碱
|
N305311-100mg
|
≥98% |
486-86-2 |
100mg
|
¥ 1544.9
|
现货 |
阿拉丁 |
CIQ,含有GluN2C / GluN2D的NMDA受体增强剂
|
C287541-5mg
|
≥98%(HPLC) |
486427-17-2 |
5mg
|
¥ 474.9
|
现货 |
阿拉丁 |
CIQ,含有GluN2C / GluN2D的NMDA受体增强剂
|
C287541-100mg
|
≥98%(HPLC) |
486427-17-2 |
100mg
|
¥ 4541.9
|
现货 |
阿拉丁 |
2-十二烷基噻吩
|
D155817-25ml
|
≥97% |
4861-61-4 |
25ml
|
¥ 3628.9
|
现货 |
阿拉丁 |
二甲基甲氧基(3,3,3-三氟丙基)硅烷
|
D352720-5g
|
≥97% |
4852-13-5 |
5g
|
¥ 1403.9
|
现货 |
阿拉丁 |
异佛手柑内酯
|
I115854-50mg
|
分析标准品, ≥98% |
482-48-4 |
50mg
|
¥ 2158.9
|
现货 |
阿拉丁 |
异佛手柑内酯
|
I115854-25mg
|
分析标准品, ≥98% |
482-48-4 |
25mg
|
¥ 1348.9
|
现货 |
阿拉丁 |